BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23143732)

  • 1. Pharmacologic management of chronic reno-cardiac syndrome.
    Hawwa N; Schreiber MJ; Tang WH
    Curr Heart Fail Rep; 2013 Mar; 10(1):54-62. PubMed ID: 23143732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially.
    Palazzuoli A; Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):503-8. PubMed ID: 21822604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-renal syndrome type 1: epidemiology, pathophysiology, and treatment.
    Ismail Y; Kasmikha Z; Green HL; McCullough PA
    Semin Nephrol; 2012 Jan; 32(1):18-25. PubMed ID: 22365158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global cardiovascular protection in chronic kidney disease.
    Ruiz-Hurtado G; Sarafidis P; Fernández-Alfonso MS; Waeber B; Ruilope LM
    Nat Rev Cardiol; 2016 Oct; 13(10):603-8. PubMed ID: 27053454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy.
    Law JP; Price AM; Pickup L; Radhakrishnan A; Weston C; Jones AM; McGettrick HM; Chua W; Steeds RP; Fabritz L; Kirchhof P; Pavlovic D; Townend JN; Ferro CJ
    J Am Heart Assoc; 2020 Apr; 9(7):e016041. PubMed ID: 32212912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel model of reno-cardiac syndrome in the C57BL/ 6 mouse strain.
    Kieswich JE; Chen J; Alliouachene S; Caton PW; McCafferty K; Thiemermann C; Yaqoob MM
    BMC Nephrol; 2018 Dec; 19(1):346. PubMed ID: 30509210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute, repetitive and chronic Takotsubo syndrome in patients with chronic kidney disease: Sympathetic reno-cardial syndrome.
    Y-Hassan S
    Int J Cardiol; 2016 Nov; 222():874-880. PubMed ID: 27522391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.
    Schmieder RE; Mitrovic V; Hengstenberg C
    Clin Res Cardiol; 2015 Aug; 104(8):621-31. PubMed ID: 25787721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular pathophysiology in chronic kidney disease: opportunities to transition from disease to health.
    Tomey MI; Winston JA
    Ann Glob Health; 2014; 80(1):69-76. PubMed ID: 24751567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current treatment in acute and chronic cardio-renal syndrome.
    Nodari S; Palazzuoli A
    Heart Fail Rev; 2011 Nov; 16(6):583-94. PubMed ID: 21136149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How should we modify recommended renin-angiotensin-aldosterone system inhibition when facing the cardiorenal syndrome?
    Sexton DJ
    Circ Heart Fail; 2014 May; 7(3):536. PubMed ID: 24847129
    [No Abstract]   [Full Text] [Related]  

  • 12. RAAS inhibition and cardiorenal syndrome.
    Onuigbo MA
    Curr Hypertens Rev; 2014; 10(2):107-11. PubMed ID: 25549841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of cardiorenal syndrome type 2 in stable chronic heart failure: workgroup statements from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Cruz DN; Schmidt-Ott KM; Vescovo G; House AA; Kellum JA; Ronco C; McCullough PA
    Contrib Nephrol; 2013; 182():117-36. PubMed ID: 23689659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-renal syndrome type 2: epidemiology, pathophysiology, and treatment.
    Jois P; Mebazaa A
    Semin Nephrol; 2012 Jan; 32(1):26-30. PubMed ID: 22365159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiorenal syndrome: an evolutionary point of view.
    Ito S
    Hypertension; 2012 Sep; 60(3):589-95. PubMed ID: 22753218
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardio-renal syndromes: from foggy bottoms to sunny hills.
    Ronco C
    Heart Fail Rev; 2011 Nov; 16(6):509-17. PubMed ID: 21259069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Cardiorenal Syndrome.
    Rubinstein J; Sanford D
    Cardiol Clin; 2019 Aug; 37(3):267-273. PubMed ID: 31279420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiorenal syndrome type 5: clinical presentation, pathophysiology and management strategies from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI).
    Mehta RL; Rabb H; Shaw AD; Singbartl K; Ronco C; McCullough PA; Kellum JA
    Contrib Nephrol; 2013; 182():174-94. PubMed ID: 23689662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cardiorenal syndrome: what the cardiologist needs to know.
    Waldum B; Os I
    Cardiology; 2013; 126(3):175-86. PubMed ID: 24022166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal Interactions Revisited: How to Improve Heart Failure Outcomes in Patients With Chronic Kidney Disease.
    Arrigo M; Cippà PE; Mebazaa A
    Curr Heart Fail Rep; 2018 Oct; 15(5):307-314. PubMed ID: 30123941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.